Swiss pharmaceutical firm Novartis has rowed back on earlier predictions that a drug to combat coronavirus could be on the horizon. CEO Vas Narasimhan says it is now more “realistic” to expect the pandemic to continue to haunt the world well into next year.
This content was published on
2 minutes
swissinfo.ch/mga
Português
pt
“Cura para Covid está mais longe do que se esperava”
Speaking to the Neue Zürcher Zeitung newspaper on Monday, Narasimhan said Covid-19 is posing more problems than expected with a series of waves striking various countries.
“The question is: When will we be so far advanced with vaccines and treatments that the world can live with the virus? We are not assuming that it will suddenly go away or that enough people will be immune,” he said.
“We are at a very early stage and it turns out that it is taking longer than we expected,” he said of finding a cure. “We hoped to be able to get more out of the existing drugs for combating Covid and also to be faster in developing a new active ingredient. Now it is clear that we need more cooperation with biotech companies.”
Novartis sold off most of its vaccines unit in 2015 and Narasimhan admitted it would be “incredibly difficult” to re-build this competence from scratch in a short period of time.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Mpox virus can also infect the brain, say Swiss scientists
This content was published on
In view of the recent worldwide increase in Mpox cases, these new findings are of great importance, according to the University of Bern.
Switzerland and Ivory Coast sign agreement on cultural assets
This content was published on
Culture Minister Elisabeth Baume-Schneider signed an agreement on cultural assets with Ivorian Culture Minister Françoise Remarck in Côte d'Ivoire on Monday. It is the first of its kind to be concluded with a country from the region.
This content was published on
A snake almost one-and-a-half metres long was discovered on Saturday in a garden in Veltheim, northern Switzerland. It was a red, black and white kingsnake.
This content was published on
The Swiss Broadcasting Corporation (SBC), Swissinfo's parent company, must restructure due to financial pressures and to stay competitive in the fast-moving media environment.
This content was published on
There has been a sharp decline in the consumption of single-use disposable plastic bags and reusable plastic bags in the Swiss retail sector.
This content was published on
A biometric Swiss identity card (ID) is expected to be available in Switzerland by the end of 2026. The Federal Office of Police and its federal and cantonal partners are working on a new ID card that features a chip.
Heatwave reduces output at Swiss nuclear power plant by 50%
This content was published on
The ongoing heatwave has forced the Beznau nuclear power plant, which relies on water from the River Aare, to halve its output.
Swiss continue to enjoy high social mobility, study shows
This content was published on
Opportunities for upward social mobility have remained intact in Switzerland since the 1980s. Social mobility is exceptionally high by international comparison, a study shows.
Swiss government affected by cyberattack on health foundation
This content was published on
Switzerland says a ransomware attack on the non-profit health foundation Radix that involved data being stolen and encrypted had also affected the federal administration.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
‘Anti-malaria drug can kill coronavirus’: Novartis chief
This content was published on
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus.
Swiss doctors call for better supplies of vaccines
This content was published on
Carlos Quinto, a board member of the Swiss Medical AssociationExternal link (FMH), told the Swiss public broadcaster SRFExternal link that stocks of Pneumovax, which helps patients with respiratory diseases or immune deficiencies to ward off pneumonia, have run out. “Patients are calling us and we then have to tell them that there is nothing left,”…
Why Switzerland’s Moderna Covid-19 vaccine deal is risky
This content was published on
Switzerland’s vaccine order – its first such move – is a sign that it holds little hope for fair distribution of a Covid-19 shot.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.